Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

@article{French1999PracticeAT,
  title={Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.},
  author={Jacqueline French and Martin Smith and Edward Faught and Lillia Brown},
  journal={Neurology},
  year={1999},
  volume={52 8},
  pages={
          1540-5
        }
}
Background/justification. Epilepsy is a common condition, affecting up to 1% of the population. Until recently, there were only a handful of effective medications to treat this condition, many of which produced unwanted side effects or were capable of producing serious adverse events in some people. Despite these drawbacks, from 1978, when valproate was introduced, until 1993, no new therapies emerged. In 1993, felbamate was approved by the Food and Drug Administration (FDA). At that time, it… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 35 CITATIONS

Lennox-Gastaut Syndrome: a Current Review

  • Current Pediatrics Reports
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 43 REFERENCES